Alphaiota

What Alphaiota does

Alphaiota is a Saudi Arabian healthcare AI company, founded in early 2021 and headquartered in Riyadh, that invests in, localizes, and deploys third-party global artificial intelligence solutions for healthcare providers in the Kingdom and the wider Middle East region. The company aggregates a portfolio of international healthcare AI vendors — including Powerful Medical (cardiac diagnostics via PMcardio), SCAI for algorithm co-development, Therapixel, Riverain Technologies, Elucid, Fabric Genomics, Dicom Systems, Huron, Informatica, Nortal, and Automation Anywhere — and distributes their capabilities into Saudi government healthcare institutions, private hospitals, and academic/research institutions through strategic partnerships with the Ministry of Health (December 2022), King Saud University (October 2024), and SDAIA/NCP-adjacent channels.

Its core products include the AI-Powered Heart Attack Diagnostic Platform (PMcardio, launched in Saudi Arabia on June 26, 2025), which detects 39 cardiac conditions and identifies heart attacks up to three hours earlier than conventional methods, plus a broader Healthcare AI Solutions Portfolio spanning diagnostic imaging, genomics, and healthcare analytics co-developed with King Saud University and SCAI. The underlying technology stack relies on partner-developed AI models rather than proprietary in-house models, with Alphaiota providing localization, integration, and clinical deployment services.

Alphaiota generates revenue through enterprise B2B licensing/royalty arrangements and managed-service contracts with healthcare institutions, operating a contact-based direct sales motion targeting enterprise healthcare leadership in Saudi Arabia. The company is privately held, operates with a small team (11–50 employees), and has not disclosed funding rounds, revenue figures, or ownership details in the public sources reviewed.

Name

Alphaiota

Legal name

Alphaiota

Website

https://alphaiota.com.sa

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Alphaiota is a Riyadh-based healthcare AI company that invests in, localizes, and deploys third-party global AI solutions — including the PMcardio cardiac diagnostic platform — for Saudi government and private healthcare providers and academic institutions in alignment with Vision 2030.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Diagnostic Imaging Centers (621512), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

AI/ML Engineering & Model Development Services (BPAEAHAF)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

Keywords

• Healthcare AI solutions
• Cardiac diagnostic software
• Medical imaging AI
• AI localization services
• Healthcare AI deployment

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Healthcare AI Solutions Deployment: Alphaiota generates revenue by investing in, localizing, and deploying global healthcare AI solutions in Saudi Arabia. Revenue comes from deploying AI diagnostic platforms, medical imaging solutions, and healthcare analytics tools to government and private healthcare institutions.
2. Strategic Partnership Services: Revenue generated through strategic partnerships with global healthcare AI companies, localizing their technologies for the Saudi market and acting as the regional deployment partner.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Alphaiota invests in, localizes, and deploys transformational AI solutions for healthcare in Saudi Arabia, functioning as the regional deployment partner for leading global healthcare AI vendors. Its portfolio spans AI-powered cardiac diagnostics (PMcardio with Powerful Medical), medical imaging AI, genomics, digital pathology, and healthcare analytics, which are deployed to government and private healthcare institutions to elevate diagnostic precision and patient care in alignment with Saudi Vision 2030.

Product overview

Alphaiota operates as an AI healthcare investment and deployment company in Saudi Arabia, functioning as a platform that invests in, localizes, and deploys leading global healthcare AI solutions. The company's portfolio includes the AI-Powered Heart Attack Diagnostic Platform (developed with Powerful Medical's PMcardio technology), co-developed AI algorithms with SCAI, and partnerships across diagnostic imaging, genomics, and data science. Alphaiota connects global healthcare AI capabilities with Saudi Arabia's Vision 2030 healthcare priorities to elevate diagnostic precision and patient care in the Kingdom and Middle East region.

Differentiator

Problem solved

Functional benefit

Products and services

• AI-Powered Heart Attack Diagnostic Platform (PMcardio) An AI-powered diagnostic platform that detects 39 cardiac conditions and identifies heart attacks up to three hours earlier than standard care, developed in partnership with Powerful Medical's PMcardio technology and deployed to Saudi healthcare institutions.
• Healthcare AI Solutions Portfolio (Localization & Deployment) End-to-end offering that invests in, localizes, and deploys a curated portfolio of leading global healthcare AI solutions (diagnostic imaging, genomics, digital pathology, healthcare analytics, and AI-driven automation) for Saudi and Middle East healthcare customers, connecting global AI capabilities with Saudi Vision 2030 healthcare priorities.

Quantifiable outcome

• Detects 39 cardiac conditions with AI-powered diagnostic platform
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Five partnerships are on record, tiered core and flagship.

• Powerful MedicalcoreTechnology or IntegrationPowerful Medical is a medical device manufacturer specializing in AI diagnostics. Alphaiota expanded strategic partnership with Powerful Medical to launch PMcardio, the first AI-powered heart attack diagnostic platform in Saudi Arabia. The platform detects 39 cardiac conditions and identifies heart attacks up to three hours earlier, part of Saudi Arabia's digital health vision.
• SCAI (Saudi Health Council)coreStrategic or Co-development PartnerAlphaiota partners with SCAI to co-develop AI algorithms to advance the local and regional healthcare sector. Partnership announced February 2024 focused on developing AI solutions for Saudi healthcare ecosystem.
• Ministry of Health (Saudi Arabia)coreStrategic or Co-development PartnerAlphaiota signed a joint cooperation agreement with the Ministry of Health in December 2022 to collaborate on healthcare AI initiatives supporting Saudi Vision 2030 healthcare transformation goals.
• King Saud UniversitycoreStrategic or Co-development PartnerStrategic cooperation agreement in genomics and data science to enhance the healthcare sector. Partnership announced October 2024 to advance research and application of AI in healthcare genomics.
• Anova HealthflagshipStrategic or Co-development PartnerStrategic partnership to adopt and develop artificial intelligence and robotics tools to elevate level of performance and efficiency in financial revenues for healthcare sector in the Kingdom. Signed July 2022 in alignment with Vision 2030 initiatives.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Fabric Genomics: Genomics AI partner already in Alphaiota's portfolio. Comparable as a clinical AI vendor whose products are localized and deployed by regional partners into hospital and research workflows.
• Lunit: Korea-based medical imaging AI company (chest X-ray, mammography, pathology) that licenses its AI to healthcare providers globally. Closely comparable in business model — a specialized AI vendor relying on regional partners to localize and commercialize clinical AI products.
• Qure.ai: AI medical imaging company selling diagnostic AI (chest X-ray, CT, head CT) to hospitals and public-health programs worldwide, with active MEA distribution. Directly comparable as a clinical imaging AI vendor with similar customer base to Alphaiota's hospital deployments.
• Aidoc: AI imaging platform for radiologists, deployed across hospital systems globally. Comparable in offering AI-driven triage and diagnostic decision-support that hospitals integrate into their radiology workflows.
• Viz.ai: AI-powered clinical decision-support for time-sensitive conditions (stroke, cardiac). Highly comparable to Alphaiota's PMcardio deployment — same category of 'AI that detects acute events earlier than conventional care.'
• Powerful Medical: Direct counterparty and core technology partner. Powerful Medical develops PMcardio, the AI cardiac diagnostic platform that Alphaiota localizes and deploys in Saudi Arabia. Both companies sell AI-driven cardiac decision-support tools to hospitals and clinicians.

Broad incumbents

• Nortal: Large systems integrator already partnering with Alphaiota. Comparable as a global IT consultancy delivering large-scale digital transformations — including healthcare — to governments, a market where Alphaiota also competes for mandate-based deployments.

Emerging players

• Infervision: Medical imaging AI vendor with a similar 'global AI vendor + regional deployment partner' go-to-market in Asia. Comparable in targeting hospital radiology departments with AI-assisted imaging workflows.

Regional players

• Altibbi: Leading MENA digital health company offering AI-enabled telehealth and health information. Comparable as a regional healthtech player serving government health initiatives and hospital ecosystems across the Arab world.
• Vezeeta: MENA-focused digital health platform serving patients and providers across the Middle East. Comparable as a regional healthcare-technology intermediary in overlapping customer segments (hospitals, government health systems).

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Alphaiota_
• LinkedInlinkedin.com/company/alphaiota

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alphaiota